Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report. [PDF]
Habibzadeh P +8 more
europepmc +1 more source
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance. [PDF]
Wright SJ +33 more
europepmc +1 more source
UV irradiation drives lineage-specific MITF-mediated transcription of PD-L1 to confer immune tolerance to UV-mutated melanocytes. [PDF]
Lo JA +35 more
europepmc +1 more source
Chemokine/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunity. [PDF]
Falahat R, Mulé JJ.
europepmc +1 more source
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours. [PDF]
Dörr J +30 more
europepmc +1 more source
Complete plastome of Coelastrum microporum Nägeli (Scenedesmaceae, Sphaeropleales). [PDF]
Lee C +6 more
europepmc +1 more source
Preclinical Evaluation of an Anchored Immunotherapy Strategy with Aluminum Hydroxide-Tethered IL-12 in Dogs with Advanced Malignant Melanoma. [PDF]
Passos Barbosa MM +8 more
europepmc +1 more source
Genetic Factors Associated with Clinical Response in Melanoma Patients Treated with Talimogene Laherparapvec: A Single-Institution Retrospective Analysis. [PDF]
Sierra-Davidson K +6 more
europepmc +1 more source
Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma. [PDF]
Karapetyan L +34 more
europepmc +1 more source

